Mayo Clinic and Virginia Tech researchers have identified five biological subtypes of MASLD, a fatty liver disease affecting nearly 30% of adults worldwide. Each carries different risks, while genetic forms may cause advanced liver damage even without obesity, diabetes or other typical metabolic fac